Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation

Journal of Immunology

Volumn 194, Issue 12, 2015, Pages 5851-5860

  Liu, Yanling ^a   Bezverbnaya, Ksenia ^a   Zhao, Tiantian ^a   Parsons, Marion J ^a   Shi, Mengyao ^a   Treanor, Bebhinn ^a,b   Ehrhardt, Götz R A ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FCRL4; FGR SRC FAMILY KINASE; GAMMA INTERFERON; HCK SRC FAMILY KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LYMPHOCYTE ANTIGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PROTEIN TYROSINE KINASE; RECEPTOR; TRANSCRIPTION FACTOR ELK 1; TYROSINE; UNCLASSIFIED DRUG; FC RECEPTOR; FCRL4 PROTEIN, HUMAN; HEMATOPOIETIC CELL KINASE; IMMUNOGLOBULIN A; ONCOPROTEIN; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FGR;

ARTICLE; ASSAY; B LYMPHOCYTE; CPG ISLAND; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; MEMORY CELL; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; CELL LINE; CHEMISTRY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MUTATION; PHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN PROCESSING;

CELL LINE; ETS-DOMAIN PROTEIN ELK-1; GENE EXPRESSION; GENES, REPORTER; HUMANS; IMMUNOGLOBULIN A; IMMUNOMODULATION; INTERFERON-GAMMA; INTERLEUKIN-10; MUTATION; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-HCK; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, FC; SRC-FAMILY KINASES;

EID: 84931346359     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401533     Document Type: Article

References (54)

1. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272: 54-60.
2. Sallusto, F., A. Lanzavecchia, K. Araki, and R. Ahmed. 2010. From vaccines to memory and back. Immunity 33: 451-463.
3. Bevan, M. J. 2011. Understand memory, design better vaccines. Nat. Immunol. 12: 463-465.
4. Klein, U., K. Rajewsky, and R. Küppers. 1998. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188: 1679-1689.
5. Ehrhardt, G. R., J. T. Hsu, L. Gartland, C. M. Leu, S. Zhang, R. S. Davis, and M. D. Cooper. 2005. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J. Exp. Med. 202: 783-791.
6. Zuccarino-Catania, G. V., S. Sadanand, F. J. Weisel, M. M. Tomayko, H. Meng, S. H. Kleinstein, K. L. Good-Jacobson, and M. J. Shlomchik. 2014. CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype. Nat. Immunol. 15: 631-637.
7. Ehrhardt, G. R., and M. D. Cooper. 2011. Immunoregulatory roles for fc receptor-like molecules. Curr. Top. Microbiol. Immunol. 350: 89-104.
8. Davis, R. S. 2007. Fc receptor-like molecules. Annu. Rev. Immunol. 25: 525-560.
9. Davis, R. S., G. R. Ehrhardt, C. M. Leu, M. Hirano, and M. D. Cooper. 2005. An extended family of Fc receptor relatives. Eur. J. Immunol. 35: 674-680.
10. Davis, R. S., Y. H. Wang, H. Kubagawa, and M. D. Cooper. 2001. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. USA 98: 9772-9777.
11. Hatzivassiliou, G., I. Miller, J. Takizawa, N. Palanisamy, P. H. Rao, S. Iida, S. Tagawa, M. Taniwaki, J. Russo, A. Neri, et al. 2001. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14: 277-289.
12. Moir, S., J. Ho, A. Malaspina, W. Wang, A. C. DiPoto, M. A. O'Shea, G. Roby, S. Kottilil, J. Arthos, M. A. Proschan, et al. 2008. Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIVinfected viremic individuals. J. Exp. Med. 205: 1797-1805.
13. Weiss, G. E., P. D. Crompton, S. Li, L. A. Walsh, S. Moir, B. Traore, K. Kayentao, A. Ongoiba, O. K. Doumbo, and S. K. Pierce. 2009. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. J. Immunol. 183: 2176-2182.
14. Kardava, L., S. Moir, W. Wang, J. Ho, C. M. Buckner, J. G. Posada, M. A. O'Shea, G. Roby, J. Chen, H. W. Sohn, et al. 2011. Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. J. Clin. Invest. 121: 2614-2624.
15. Yeo, L., H. Lom, M. Juarez, M. Snow, C. D. Buckley, A. Filer, K. Raza, and D. Scheel-Toellner. 2015. Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis. Ann. Rheum. Dis. 74: 928-935.
16. Ehrhardt, G. R., R. S. Davis, J. T. Hsu, C. M. Leu, A. Ehrhardt, and M. D. Cooper. 2003. The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc. Natl. Acad. Sci. USA 100: 13489-13494.
17. Jackson, T. A., C. L. Haga, G. R. Ehrhardt, R. S. Davis, and M. D. Cooper. 2010. FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells. J. Immunol. 185: 7405-7412.
18. Haga, C. L., G. R. Ehrhardt, R. J. Boohaker, R. S. Davis, and M. D. Cooper. 2007. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Proc. Natl. Acad. Sci. USA 104: 9770-9775.
19. Zhu, Z., R. Li, H. Li, T. Zhou, and R. S. Davis. 2013. FCRL5 exerts binary and compartment-specific influence on innate-like B-cell receptor signaling. Proc. Natl. Acad. Sci. USA 110: E1282-E1290.
20. Leu, C. M., R. S. Davis, L. A. Gartland, W. D. Fine, and M. D. Cooper. 2005. FcRH1: an activation coreceptor on human B cells. Blood 105: 1121-1126.
21. Li, F. J., D. M. Schreeder, R. Li, J. Wu, and R. S. Davis. 2013. FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation. Eur. J. Immunol. 43: 2980-2992.
22. Ehrhardt, G. R., A. Hijikata, H. Kitamura, O. Ohara, J. Y. Wang, and M. D. Cooper. 2008. Discriminating gene expression profiles of memory B cell subpopulations. J. Exp. Med. 205: 1807-1817.
23. Barrow, A. D., and J. Trowsdale. 2006. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling. Eur. J. Immunol. 36: 1646-1653.
24. Sohn, H. W., P. D. Krueger, R. S. Davis, and S. K. Pierce. 2011. FcRL4 acts as an adaptive to innate molecular switch dampening BCR signaling and enhancing TLR signaling. Blood 118: 6332-6341.
25. Ehrhardt, G. R., K. B. Leslie, F. Lee, J. S. Wieler, and J. W. Schrader. 1999. M-Ras, a widely expressed 29-kD homologue of p21 Ras: expression of a constitutively active mutant results in factor-independent growth of an interleukin-3-dependent cell line. Blood 94: 2433-2444.
26. Lock, P., S. Ralph, E. Stanley, I. Boulet, R. Ramsay, and A. R. Dunn. 1991. Two isoforms of murine hck, generated by utilization of alternative translational initiation codons, exhibit different patterns of subcellular localization. Mol. Cell. Biol. 11: 4363-4370.
27. Godbey, W. T., K. K. Wu, and A. G. Mikos. 1999. Poly(ethylenimine) and its role in gene delivery. J. Control. Release 60: 149-160.
28. Ehrhardt, G. R., C. Korherr, J. S. Wieler, M. Knaus, and J. W. Schrader. 2001. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth. Oncogene 20: 188-197.
29. Cheng, P. C., M. L. Dykstra, R. N. Mitchell, and S. K. Pierce. 1999. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J. Exp. Med. 190: 1549-1560.
30. Wilson, T. J., A. Fuchs, and M. Colonna. 2012. Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG. J. Immunol. 188: 4741-4745.
31. Crise, B., and J. K. Rose. 1992. Identification of palmitoylation sites on CD4, the human immunodeficiency virus receptor. J. Biol. Chem. 267: 13593-13597.
32. Fragoso, R., D. Ren, X. Zhang, M. W. Su, S. J. Burakoff, and Y. J. Jin. 2003. Lipid raft distribution of CD4 depends on its palmitoylation and association with Lck, and evidence for CD4-induced lipid raft aggregation as an additional mechanism to enhance CD3 signaling. J. Immunol. 170: 913-921.
33. Arcaro, A., C. Grégoire, N. Boucheron, S. Stotz, E. Palmer, B. Malissen, and I. F. Luescher. 2000. Essential role of CD8 palmitoylation in CD8 coreceptor function. J. Immunol. 165: 2068-2076.
34. Pang, D. J., A. C. Hayday, and M. J. Bijlmakers. 2007. CD8 Raft localization is induced by its assembly into CD8alpha beta heterodimers, Not CD8alpha alpha homodimers. J. Biol. Chem. 282: 13884-13894.
35. Dykstra, M., A. Cherukuri, H. W. Sohn, S. J. Tzeng, and S. K. Pierce. 2003. Location is everything: lipid rafts and immune cell signaling. Annu. Rev. Immunol. 21: 457-481.
36. Levental, I., M. Grzybek, and K. Simons. 2010. Greasing their way: lipid modifications determine protein association with membrane rafts. Biochemistry 49: 6305-6316.
37. Levental, I., D. Lingwood, M. Grzybek, U. Coskun, and K. Simons. 2010. Palmitoylation regulates raft affinity for the majority of integral raft proteins. Proc. Natl. Acad. Sci. USA 107: 22050-22054.
38. Sharrocks, A. D. 2001. The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2: 827-837.
39. Bouaziz, J. D., S. Calbo, M. Maho-Vaillant, A. Saussine, M. Bagot, A. Bensussan, and P. Musette. 2010. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur. J. Immunol. 40: 2686-2691.
40. Liang, X., E. A. Moseman, M. A. Farrar, V. Bachanova, D. J. Weisdorf, B. R. Blazar, and W. Chen. 2010. Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells. Blood 115: 5041-5052.
41. Lund, F. E., and T. D. Randall. 2010. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat. Rev. Immunol. 10: 236-247.
42. Taguchi, T., N. Kiyokawa, N. Sato, M. Saito, and J. Fujimoto. 2000. Characteristic expression of Hck in human B-cell precursors. Exp. Hematol. 28: 55-64.
43. Podar, K., G. Mostoslavsky, M. Sattler, Y. T. Tai, T. Hayashi, L. P. Catley, T. Hideshima, R. C. Mulligan, D. Chauhan, and K. C. Anderson. 2004. Critical role for hematopoietic cell kinase (Hck)-mediated phosphorylation of Gab1 and Gab2 docking proteins in interleukin 6-induced proliferation and survival of multiple myeloma cells. J. Biol. Chem. 279: 21658-21665.
44. Hu, Y., Y. Liu, S. Pelletier, E. Buchdunger, M. Warmuth, D. Fabbro, M. Hallek, R. A. Van Etten, and S. Li. 2004. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nat. Genet. 36: 453-461.
45. Wang, L., R. A. Gordon, L. Huynh, X. Su, K. H. Park Min, J. Han, J. S. Arthur, G. D. Kalliolias, and L. B. Ivashkiv. 2010. Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity 32: 518-530.
46. Ivashkiv, L. B. 2008. A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways. Nat. Rev. Immunol. 8: 816-822.
47. Ivashkiv, L. B. 2009. Cross-regulation of signaling by ITAM-associated receptors. Nat. Immunol. 10: 340-347.
48. Lingwood, D., and K. Simons. 2010. Lipid rafts as a membrane-organizing principle. Science 327: 46-50.
49. Zaman, S. N., M. E. Resek, and S. M. Robbins. 2008. Dual acylation and lipid raft association of Src-family protein tyrosine kinases are required for SDF-1/CXCL12-mediated chemotaxis in the Jurkat human T cell lymphoma cell line. J. Leukoc. Biol. 84: 1082-1091.
50. Séverin, S., C. A. Nash, J. Mori, Y. Zhao, C. Abram, C. A. Lowell, Y. A. Senis, and S. P. Watson. 2012. Distinct and overlapping functional roles of Src family kinases in mouse platelets. J. Thromb. Haemost. 10: 1631-1645.
51. Saeki, K., Y. Miura, D. Aki, T. Kurosaki, and A. Yoshimura. 2003. The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction. EMBO J. 22: 3015-3026.
52. Carréno, S., E. Caron, C. Cougoule, L. J. Emorine, and I. Maridonneau-Parini. 2002. p59Hck isoform induces F-actin reorganization to form protrusions of the plasma membrane in a Cdc42- and Rac-dependent manner. J. Biol. Chem. 277: 21007-21016.
53. Möhn, H., V. Le Cabec, S. Fischer, and I. Maridonneau-Parini. 1995. The src-family protein-tyrosine kinase p59hck is located on the secretory granules in human neutrophils and translocates towards the phagosome during cell activation. Biochem. J. 309: 657-665.
54. Carréno, S., M. E. Gouze, S. Schaak, L. J. Emorine, and I. Maridonneau-Parini. 2000. Lack of palmitoylation redirects p59Hck from the plasma membrane to p61Hck-positive lysosomes. J. Biol. Chem. 275: 36223-36229.